Synthetic Biologics Inc. Shares Close in on 52-Week Low - Market Mover
The shares closed 2.0% above its 52-week low of $0.26, with trading volume lower than its 30 day average
Jan 13, 2022 by Kwhen Finance Editors
Synthetic Biologics Inc. (SYN) shares closed today at 2.0% above its 52 week low of $0.26, giving the company a market cap of $36M. The stock is currently up 2.3% year-to-date, down 68.2% over the past 12 months, and down 99.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%.
Trading Activity
- Trading volume this week was 55.5% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Synthetic Biologics Inc. | -6.6 | 2.3 | -68.2 | -77.0 | 9.8 |
| Dow Jones Industrial Average | -0.5 | -0.1 | 18.8 | -1.6 | 23.8 |
| S&P 500 Index | -1.4 | -0.8 | 26.0 | -1.7 | 29.8 |
| Health Care | -1.8 | -3.8 | 15.2 | -4.5 | 22.7 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 258.5%
- The company's stock price performance over the past 12 months lags the peer average by -729.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | SYN | 0 | 2.3 | -68.2 | -77.0 | 9.8 |
| Peer Avg | N/A | 39.1 | 0.6 | 10.8 | -9.6 | 93.7 |
| Pfizer Inc. | PFE | 16.6 | -4.1 | 58.3 | -8.4 | 74.2 |
| Abbott Laboratories | ABT | 32.5 | -5.0 | 24.8 | -6.8 | 27.1 |
| Merck & Co Inc | MRK | 28.5 | 5.9 | 1.3 | -10.6 | 442.8 |
| Astrazeneca plc - ADR | AZN | 121.6 | 0.3 | 19.3 | ||
| Biogen Inc | BIIB | 21.4 | -6.1 | -15.7 | ||
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 13.7 | 12.7 | -23.0 | -31.5 | 17.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: